Fibrosing cholestatic hepatitis and HBV after bone marrow transplantation
- 31 December 1995
- journal article
- review article
- Published by Elsevier BV in Biomedicine & Pharmacotherapy
- Vol. 49 (3), 117-124
- https://doi.org/10.1016/0753-3322(96)82604-7
Abstract
No abstract availableKeywords
This publication has 40 references indexed in Scilit:
- Hepatitis B virus heterogeneity, one of many factors influencing the severity of hepatitis BJournal of Hepatology, 1993
- Hepatitis B virus (HBV) precore mutant associated with fibrosing cholestatic hepatitis after orthotopic liver transplant(OLT)Hepatology, 1993
- Reactivation of precore mutant hepatitis B virus leading to fulminant hepatic failure following cytotoxic treatmentDigestive Diseases and Sciences, 1992
- Liver transplantation for patients with hepatitis B: What have we learned from our results?Hepatology, 1991
- Immunoelectron microscopic observation of intrahepatic HBeAg in patients with chronic hepatitis BHepatology, 1990
- CHANGING OF HEPATITIS B VIRUS MARKERS IN PATIENTS WITH BONE MARROW TRANSPLANTATIONTransplantation, 1990
- Recurrence of hepatitis B in children with serologic evidence of past hepatitis B virus infection undergoing antileukemic chemotherapyJournal of Hepatology, 1989
- Natural history of chronic hepatitis B virus-related liver disease and its relationship to serum markers of viral replicationJournal of Hepatology, 1986
- TRANSFER OF A FUNCTIONING HUMORAL IMMUNE SYSTEM IN TRANSPLANTATION OF T-LYMPHOCYTE-DEPLETED BONE MARROWThe Lancet, 1986
- Hepatitis B virus DNA in the sera of HBsAg carriers: A marker of active hepatitis B virus replication in the liverHepatology, 1981